Fermenta Biotech Latest Share Price (FERMENTA)
TODAY IN ONE LINE
FERMENTA fell 1.4%, lagging Nifty's 0.5% move.
With a market cap of ₹1,383.26 Cr., it trades at a P/E of 23.48. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
Fermenta Biotech flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●High Capital EfficiencyROCE of 20.4% indicating pricing power
- ●Strong Return on EquityHealthy ROE of 17.4%
- ●Healthy Operating MarginsOPM is structurally strong at 19.0%
- ●Reasonable ValuationTrading at a moderate P/E of 15.3x
- ●High Promoter HoldingPromoters hold 64.1% skin-in-the-game
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.28x
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Sales ContractionQuarterly sales dropped 13.1% YoY
Latest Fermenta Biotech News
What changed recently?
Recent events, corporate actions, and announcements.
Fermenta Biotech Ltd valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Fermenta Biotech Ltd, framed against the sector median so the premium or discount is obvious at a glance.
Fermenta Biotech Ltd trades at a P/E of 23.48× and P/B of 3.46×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
Fermenta Biotech Ltd technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for Fermenta Biotech Ltd — derived from the latest tape, not yesterday's close.
Fermenta Biotech Ltd last traded at ₹468.4 with an intraday range of ₹456.05–₹480 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹468.40| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 528.15 | +59.75 | +12.76% |
| R3 | 504.20 | +35.80 | +7.64% |
| R2 | 492.10 | +23.70 | +5.06% |
| R1 | 480.25 | +11.85 | +2.53% |
| PIVOT | 468.15 | -0.25 | -0.05% |
| CURRENT | 468.40 | — | — |
| S1 | 456.30 | -12.10 | -2.58% |
| S2 | 444.20 | -24.20 | -5.17% |
| S3 | 432.35 | -36.05 | -7.70% |
| S4 | 408.40 | -60.00 | -12.81% |
FERMENTA is trading Above CPR, indicating Bullishness
CPR is Narrower, suggesting likely for trending moves
Day's range: ₹470–₹480
Trading Below opening range, showing Bearishness
Fermenta Biotech Ltd financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for Fermenta Biotech Ltd — consolidated or standalone — with margins, YoY growth and key ratios inline.
Fermenta Biotech Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹1,383.26 Cr. and reported EPS of ₹24.40.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 469 | 525 ▲ 11.9% |
| Sales Growth YoY %Derived | 39.87% | 11.92% |
| Other Income | 12 | 22 ▲ 89.4% |
| Total Income | 481 | 548 ▲ 13.8% |
| 147 | 192 ▲ 30.2% | |
| Gross ProfitDerived | 322 | 333 ▲ 3.5% |
| Gross Margin %Derived | 68.60% | 63.47% |
| 212 | 234 ▲ 10.1% | |
| EBITDA (Operating Profit)Derived | 110 | 100 ▼ 9.1% |
| OPM %Derived | 23.39% | 19.00% |
| 38 | 40 ▲ 4.4% | |
| Profit Before Tax (PBT) | 83 | 96 ▲ 15.2% |
| 7 | 26 ▲ 276.3% | |
| Effective Tax %Derived | 8.18% | 26.71% |
| Total Profit for Period | 76 | 70 ▼ 8.0% |
| Less: Non-controlling Interests | — | — |
| Net Profit (Owner's PAT)Derived | 76 | 70 ▼ 8.0% |
| Net Profit Margin %Derived | 16.27% | 13.37% |
| PAT Growth YoY %Derived | 418.23% | -8.05% |
| Earnings Per Share (EPS ₹) | 25.96 | 23.87 ▼ 8.1% |
| Diluted Shares Outstanding (Cr) | 3 | 3 ▲ 0.0% |
| Share of Profit from Associates/JVs | — | — |
| Other Comprehensive Income (Net of Tax) | -2 | -7 ▼ 246.8% |
| Total Expenses (incl. D&A & Interest) | 398 | 452 ▲ 13.5% |
| Material Cost % of RevenueDerived | 25.33% | 28.31% |
| Employee Cost % of RevenueDerived | 13.87% | 15.72% |
| Other Cost % of RevenueDerived | 31.35% | 28.75% |
| Interest Coverage (x)Derived | 6.03x | 6.77x |
| Period | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 405 | 293 ▼ 27.6% | 377 ▲ 28.8% | 399 ▲ 5.6% | 350 ▼ 12.2% | 336 ▼ 4.1% | 469 ▲ 39.9% | 525 ▲ 11.9% | |
| Sales Growth YoY %Derived | — | -27.61% | 28.79% | 5.63% | -12.19% | -4.08% | 39.87% | 11.92% | |
| Other Income | 12 | 12 ▼ 0.3% | 8 ▼ 33.0% | 8 ▼ 1.4% | 8 ▼ 5.4% | 11 ▲ 45.6% | 12 ▲ 5.5% | 22 ▲ 89.4% | |
| Total Income | 417 | 305 ▼ 26.8% | 386 ▲ 26.3% | 407 ▲ 5.5% | 358 ▼ 12.1% | 347 ▼ 3.0% | 481 ▲ 38.8% | 548 ▲ 13.8% | |
92 | 79 ▼ 14.3% | 134 ▲ 70.0% | 153 ▲ 14.0% | 154 ▲ 0.3% | 130 ▼ 15.2% | 147 ▲ 13.3% | 192 ▲ 30.2% | ||
| Gross ProfitDerived | 312 | 214 ▼ 31.5% | 243 ▲ 13.6% | 245 ▲ 1.0% | 196 ▼ 20.0% | 206 ▲ 4.7% | 322 ▲ 56.7% | 333 ▲ 3.5% | |
| Gross Margin %Derived | 77.20% | 73.02% | 64.38% | 61.57% | 56.12% | 61.23% | 68.60% | 63.47% | |
164 | 149 ▼ 9.1% | 161 ▲ 8.5% | 184 ▲ 14.0% | 178 ▼ 3.0% | 177 ▼ 0.6% | 212 ▲ 19.7% | 234 ▲ 10.1% | ||
| EBITDA (Operating Profit)Derived | 149 | 65 ▼ 56.2% | 82 ▲ 25.2% | 61 ▼ 24.7% | 18 ▼ 70.8% | 28 ▲ 56.7% | 110 ▲ 290.5% | 100 ▼ 9.1% | |
| OPM %Derived | 36.79% | 22.27% | 21.64% | 15.42% | 5.13% | 8.38% | 23.39% | 19.00% | |
33 | 34 ▲ 4.9% | 38 ▲ 12.1% | 43 ▲ 11.4% | 21 ▼ 51.8% | 34 ▲ 67.1% | 38 ▲ 11.9% | 40 ▲ 4.4% | ||
| Profit Before Tax (PBT) | 129 | 43 ▼ 66.3% | 52 ▲ 18.9% | 27 ▼ 47.8% | -52 ▼ 292.5% | -10 ▲ 81.0% | 83 ▲ 942.8% | 96 ▲ 15.2% | |
11 | -16 ▼ 249.0% | 9 ▲ 156.5% | 12 ▲ 30.6% | 2 ▼ 85.9% | 14 ▲ 741.1% | 7 ▼ 51.9% | 26 ▲ 276.3% | ||
| Effective Tax %Derived | 8.39% | -37.08% | 17.63% | 44.10% | -3.24% | -143.18% | 8.18% | 26.71% | |
| Total Profit for Period | 117 | 60 ▼ 49.3% | 43 ▼ 28.5% | 15 ▼ 64.6% | -54 ▼ 455.6% | -24 ▲ 55.2% | 76 ▲ 418.2% | 70 ▼ 8.0% | |
| Less: Non-controlling Interests | -7 | — ▲ 100.0% | — | — | — | — | — | — | |
| Net Profit (Owner's PAT)Derived | 125 | 60 ▼ 52.2% | 43 ▼ 28.5% | 15 ▼ 64.6% | -54 ▼ 455.6% | -24 ▲ 55.2% | 76 ▲ 418.2% | 70 ▼ 8.0% | |
| Net Profit Margin %Derived | 30.79% | 20.32% | 11.27% | 3.78% | -15.30% | -7.15% | 16.27% | 13.37% | |
| PAT Growth YoY %Derived | — | -52.23% | -28.54% | -64.59% | -455.59% | 55.17% | 418.23% | -8.05% | |
| Earnings Per Share (EPS ₹) | 45.28 | 20.22 ▼ 55.3% | 14.45 ▼ 28.5% | 5.12 ▼ 64.6% | -18.20 ▼ 455.5% | -8.16 ▲ 55.2% | 25.96 ▲ 418.1% | 23.87 ▼ 8.1% | |
| Diluted Shares Outstanding (Cr) | 3 | 3 ▲ 7.0% | 3 ▲ 0.0% | 3 ▲ 0.0% | 3 ▲ 0.0% | 3 ▲ 0.0% | 3 ▲ 0.0% | 3 ▲ 0.0% | |
| Share of Profit from Associates/JVs | -0 | — ▲ 100.0% | — | — | — | — | — | — | |
| Other Comprehensive Income (Net of Tax) | -1 | 2 ▲ 228.0% | -0 ▼ 114.3% | 1 ▲ 325.0% | -1 ▼ 340.6% | -0 ▲ 89.5% | -2 ▼ 1135.9% | -7 ▼ 246.8% | |
| Total Expenses (incl. D&A & Interest) | 288 | 262 ▼ 9.2% | 334 ▲ 27.5% | 380 ▲ 13.7% | 410 ▲ 7.8% | 357 ▼ 12.9% | 398 ▲ 11.6% | 452 ▲ 13.5% | |
| Material Cost % of RevenueDerived | 25.50% | 36.05% | 37.62% | 33.17% | 32.01% | 22.94% | 25.33% | 28.31% | |
| Employee Cost % of RevenueDerived | 13.14% | 17.08% | 15.43% | 15.80% | 16.55% | 17.44% | 13.87% | 15.72% | |
| Other Cost % of RevenueDerived | 27.27% | 33.68% | 27.31% | 30.35% | 34.45% | 35.41% | 31.35% | 28.75% | |
| Interest Coverage (x)Derived | 6.63x | 2.62x | 3.41x | 2.10x | -0.50x | 0.20x | 6.03x | 6.77x |
Fermenta Biotech segment analysis : revenue and profit mix.
Disclosed business segments at Fermenta Biotech with their share of revenue and profit, switchable between consolidated and standalone reporting.
Fermenta Biotech discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Fermenta Biotech Ltd.
Our AI distills the core fundamental drivers supporting Fermenta Biotech Ltd, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
What you're getting.
No strengths or opportunities on record.
Key Risks.
No weaknesses or threats on record.
Flip Conditions.
Valuation risk. a P/E above 31 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 12% would indicate weaker capital compounding.
Fermenta Biotech Ltd peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Fermenta Biotech Ltd is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
Fermenta Biotech Ltd chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Fermenta Biotech Ltd — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
Fermenta Biotech Ltd delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Fermenta Biotech Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Fermenta Biotech Ltd stood at 54.9% of traded volume, against a 20-day average of 45.7%.
Fermenta Biotech announcements: results, concalls, ratings, M&A.
Filings Fermenta Biotech sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Fermenta Biotech files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 83 documents below.
Analysts/Institutional Investor Meet/Con. Call Updates
Fermenta Biotech Limited has informed the Exchange about Schedule of investor(s) meeting to be held on August 21, 2026.
Credit Rating- Revision
Fermenta Biotech Limited has informed the Exchange about Revision in Credit Rating.
Copy of Newspaper Publication
Fermenta Biotech Limited has informed the Exchange about Copy of Newspaper Publication pertaining to unaudited Financial Results (Standalone and…
General Updates
Fermenta Biotech Limited has informed the Exchange about Declaration of Voting Results of the 74th Annual General Meeting.
Shareholders meeting
Fermenta Biotech Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 11, 2026. Further, the…
Investor decks & rating reports.
Fermenta Biotech dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Fermenta Biotech has declared, sequenced by announce and record date.
Fermenta Biotech corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Fermenta Biotech Ltd: business, sector, key facts.
What Fermenta Biotech Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Fermenta Biotech Ltd is a listed Indian equity, listed as NSE: FERMENTA, BSE: 506414.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- 3B Blackbio DX (3BBLACKBIO) Share PricePeer
- Abbott India (ABBOTINDIA) Share PricePeer
- Acutaas Chemicals (ACUTAAS) Share PricePeer
- Anlon Healthcare (AHCL) Share PricePeer
- Amanta Healthcare (AMANTA) Share PricePeer
- Other undervalued NSE stocksScreener
- Quality + Value Portfolio strategyStrategy
- Top quality scorecard stocksScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about Fermenta Biotech Ltd (FERMENTA).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Fermenta Biotech Ltd (FERMENTA)?
The current share price of Fermenta Biotech Ltd (FERMENTA) is ₹468.40. Today, the stock has declined by ₹6.70 (1.41%), trading in a range of ₹456.05 to ₹480.00. The stock opened at ₹480.00 with a trading volume of 91,861 shares.
02Is Fermenta Biotech Ltd stock a good investment for long-term?
Fermenta Biotech Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹1,383.26 Cr., P/E ratio of 23.48, ROE of 17.4%, and ROCE of 20.4%. The dividend yield stands at 0.62%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Fermenta Biotech Ltd stock?
The 52-week high price of Fermenta Biotech Ltd (FERMENTA) is ₹580.45, while the 52-week low is ₹248.85. Currently trading at ₹468.40, the stock is 88.23% above its 52-week low and 19.3% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Fermenta Biotech Ltd stock at the current price?
Whether to buy Fermenta Biotech Ltd stock at ₹468.40 depends on multiple factors. The stock is currently trading with a P/E ratio of 23.48 and P/B ratio of 3.46. Today's performance shows a loss of 1.41%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Fermenta Biotech Ltd and when is the next dividend?
Fermenta Biotech Ltd offers a dividend yield of 0.62%, which means for every ₹100 invested at the current price of ₹468.40, you can expect to receive approximately ₹0.62 annually as dividends. The face value of the stock is ₹5.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Fermenta Biotech Ltd?
Fermenta Biotech Ltd's key financial metrics include: P/E Ratio: 23.48, P/B Ratio: 3.46, ROE: 17.4%, ROCE: 20.4%, Dividend Yield: 0.62%, EPS: ₹24.40, Book Value: ₹138.00, and Debt-to-Equity: 0.28. The company's market cap stands at ₹1,383.26 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Fermenta Biotech Ltd stock performing today in the market?
Fermenta Biotech Ltd stock opened at ₹480.00 and is currently trading at ₹468.40, showing a decline of ₹6.70 (1.41%). The intraday high is ₹480.00 and low is ₹456.05. The trading volume stands at 91,861 shares, indicating moderate market participation today.
08What is the P/E ratio of Fermenta Biotech Ltd and what does it indicate?
Fermenta Biotech Ltd has a Price-to-Earnings (P/E) ratio of 23.48, which means investors are willing to pay 23.48 for every ₹1 of earnings. With an EPS of ₹24.40, this P/E ratio indicates moderate valuation in line with market standards. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Fermenta Biotech Ltd (FERMENTA) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.